Cargando…
Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis
Despite relevant advances made in therapies for cardiovascular diseases (CVDs), they still represent the first cause of death worldwide. Cardiac fibrosis and excessive extracellular matrix (ECM) remodeling are common end-organ features in diseased hearts, leading to tissue stiffness, impaired myocar...
Autores principales: | Baci, Denisa, Bosi, Annalisa, Parisi, Luca, Buono, Giuseppe, Mortara, Lorenzo, Ambrosio, Giuseppe, Bruno, Antonino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583949/ https://www.ncbi.nlm.nih.gov/pubmed/32998408 http://dx.doi.org/10.3390/ijms21197165 |
Ejemplares similares
-
The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors
por: Baci, Denisa, et al.
Publicado: (2020) -
Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?
por: Parisi, Luca, et al.
Publicado: (2018) -
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors
por: Gallazzi, Matteo, et al.
Publicado: (2021) -
Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients
por: Baci, Denisa, et al.
Publicado: (2022) -
Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression
por: Bruno, Antonino, et al.
Publicado: (2019)